ResMed Inc
0KW4.L
$277.94 1.30%
Exchange: LSE | Sector: Healthcare | Industry: Medical Equipment Services
Q1 2025
Published: Oct 25, 2024

Earnings Highlights

  • Revenue of $1.22B up 27.2% year-over-year
  • EPS of $2.11 increased by 42.3% from previous year
  • Gross margin of 58.6%
  • Net income of 311.36M
  • ""Our focus on enhancing patient outcomes through technology is why we see less price sensitivity in our segments, leading to sustained demand despite challenging economic conditions."" - Mick Farrell, CEO

ResMed Inc (0KW4.L) Q1 2025 Financial Results: Robust Growth Amid Market Efforts

Executive Summary

ResMed Inc (0KW4.L) reported a robust performance for Q1 2025, achieving a revenue of $1.22 billion, marking a year-over-year increase of 27.15%. This quarterly performance reflects the companyÒ€ℒs continued focus on its core sectors Γ’β‚¬β€œ Sleep and Respiratory Care and Software as a Service, adapting to evolving healthcare needs. Management has emphasized strategic investments into innovation as well as expanding their global footprint, majorly contributing to this success. The net income surged to $311 million, a 41.90% increase compared to the previous year, underscoring effective operational efficiency and enhanced profitability. ManagementÒ€ℒs guidance suggests a positive outlook for the upcoming quarters, bolstered by new product releases and market expansions, which investors should watch closely.

Key Performance Indicators

Revenue

1.22B
QoQ: 0.11% | YoY:27.15%

Gross Profit

717.22M
58.57% margin
QoQ: 1.84% | YoY:19.52%

Operating Income

387.31M
QoQ: 1.60% | YoY:34.02%

Net Income

311.36M
QoQ: 6.54% | YoY:41.90%

EPS

2.12
QoQ: 6.53% | YoY:42.28%

Revenue Trend

Margin Analysis

Key Insights

  • **Revenue**: $1.22 billion, up 27.15% YoY and 0.11% QoQ
  • **Gross Profit**: $717.22 million, Gross Margin: 58.57% (YoY: +19.52%, QoQ: +1.84%)
  • **Operating Income**: $387.31 million, Operating Margin: 31.63% (YoY: +34.02%, QoQ: +1.60%)
  • **Net Income**: $311.36 million, Net Margin: 25.43% (YoY: +41.90%, QoQ: +6.54%)
  • **EPS**: $2.12, an increase of 42.28% YoY and 6.53% QoQ.

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 1,291.74 2.48 +7.9% View
Q2 2025 1,282.09 2.34 +10.3% View
Q1 2025 1,224.51 2.11 +27.2% View
Q4 2024 1,223.20 1.98 +9.0% View
Q3 2024 1,196.98 2.04 +7.2% View